Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
10.25
-0.65 (-5.96%)
Nov 21, 2024, 12:11 PM EST - Market open
Avalo Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -7.96 | -31.54 | -41.66 | -84.38 | -63.5 | -16.07 | Upgrade
|
| Depreciation & Amortization | 0.14 | 0.16 | 0.17 | 1.66 | 1.84 | 1.46 | Upgrade
|
| Other Amortization | - | 1.83 | 1.39 | 0.79 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 31.55 | 3.91 | - | - | 25.55 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -5.21 | -0.05 | Upgrade
|
| Stock-Based Compensation | 3.72 | 3.48 | 7.55 | 8.17 | 6.79 | 2.53 | Upgrade
|
| Other Operating Activities | -60.23 | 0.73 | 5.86 | 0.02 | -1.57 | -0.88 | Upgrade
|
| Change in Accounts Receivable | - | - | 1.06 | 1.12 | -0.68 | 1.66 | Upgrade
|
| Change in Inventory | - | 0.02 | 0.02 | -0.04 | 0.02 | 0.53 | Upgrade
|
| Change in Accounts Payable | 1.02 | -2.44 | -0.49 | 0.8 | 0.1 | 1.02 | Upgrade
|
| Change in Unearned Revenue | -0.09 | -0.09 | 0.09 | - | - | - | Upgrade
|
| Change in Income Taxes | - | - | - | - | 0.29 | -1.48 | Upgrade
|
| Change in Other Net Operating Assets | -4.95 | -6.74 | -0.74 | 0.96 | -4.16 | -3.76 | Upgrade
|
| Operating Cash Flow | -36.78 | -30.68 | -26.75 | -70.89 | -40.54 | -19.13 | Upgrade
|
| Capital Expenditures | - | -0.16 | -0.1 | -0.11 | -0.06 | -0.26 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.03 | - | - | - | - | Upgrade
|
| Cash Acquisitions | 0.36 | - | - | - | -1.64 | - | Upgrade
|
| Investment in Securities | - | - | - | - | 12.84 | - | Upgrade
|
| Other Investing Activities | - | - | - | - | - | 3.96 | Upgrade
|
| Investing Cash Flow | 0.36 | -0.13 | -0.1 | -0.11 | 11.13 | -0.44 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 32.9 | - | - | Upgrade
|
| Total Debt Issued | - | - | - | 32.9 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -21.24 | -14.81 | - | - | -0.26 | Upgrade
|
| Net Debt Issued (Repaid) | - | -21.24 | -14.81 | 32.9 | - | -0.26 | Upgrade
|
| Issuance of Common Stock | 115.63 | 46.29 | 0.11 | 73.86 | 44.88 | 13.73 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -0.09 | -0.03 | Upgrade
|
| Other Financing Activities | -7.49 | - | - | - | - | -0.88 | Upgrade
|
| Financing Cash Flow | 108.14 | 25.04 | -14.7 | 106.76 | 44.78 | 12.56 | Upgrade
|
| Net Cash Flow | 71.72 | -5.77 | -41.55 | 35.76 | 15.38 | -7.02 | Upgrade
|
| Free Cash Flow | -36.78 | -30.84 | -26.85 | -71.01 | -40.6 | -19.4 | Upgrade
|
| Free Cash Flow Margin | -4485.12% | -1602.81% | -148.72% | -1315.39% | -606.09% | -287.34% | Upgrade
|
| Free Cash Flow Per Share | -17.77 | -111.04 | -684.81 | -1961.95 | -1591.55 | -977.20 | Upgrade
|
| Cash Interest Paid | - | 1.93 | 2.93 | 1.59 | - | 1.05 | Upgrade
|
| Cash Income Tax Paid | - | - | - | - | 0.47 | 1.8 | Upgrade
|
| Levered Free Cash Flow | 39.64 | -20.79 | -12.04 | -37.89 | -11.17 | -25.51 | Upgrade
|
| Unlevered Free Cash Flow | 39.64 | -20.48 | -10.82 | -37.19 | -11.17 | -25.51 | Upgrade
|
| Change in Net Working Capital | -52.84 | 9.31 | -0.27 | -4.43 | -9.82 | 17.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.